Microvascular footprint of COVID infection in nuclear cardiology
- 29 May 2026
- journal article
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 59, 102732
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Association of prior severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronary microvascular dysfunction: A pilot studyJournal of Nuclear Cardiology, 2026
- Clinical Implications of COVID-19-Related Endothelial DysfunctionJACC: Advances, 2024
- Coronary microvascular health in symptomatic patients with prior COVID-19 infection: an updated analysisEuropean Heart Journal - Cardiovascular Imaging, 2023
- Prediction of outcome by 82Rb PET/CT in patients with ischemia and nonobstructive coronary arteriesJournal of Nuclear Cardiology, 2022
- Correction to: Relation between myocardial blood flow and cardiac events in diabetic patients with suspected coronary artery disease and normal myocardial perfusion imagingJournal of Nuclear Cardiology, 2022
- Impact of COVID-19 infection on short-term outcome in patients referred to stress myocardial perfusion imagingEuropean Journal of Nuclear Medicine and Molecular Imaging, 2021
- Effects of the COVID-19 pandemic on myocardial perfusion imaging for ischemic heart diseaseEuropean Journal of Nuclear Medicine and Molecular Imaging, 2020
- Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)JAMA Cardiology, 2020
- Endothelial cell infection and endotheliitis in COVID-19The Lancet, 2020
- Coronary Microvascular Disease Pathogenic Mechanisms and Therapeutic OptionsJACC, 2018